Group One Trading
NYMX

Group One Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Group One Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-900
Closed -$171 – 8671
2023
Q2 		$171 Buy
+900
New +$354 ﹤0.01% 7479
2023
Q1 		– Sell
-3,700
Closed -$1.1K – 8221
2022
Q4 		$1.1K Buy
+3,700
New +$1.34K ﹤0.01% 6811
2022
Q2 		– Sell
-10,100
Closed -$13K – 8788
2022
Q1 		$13K Buy
10,100
+6,200
+159% +$9.57K ﹤0.01% 7065
2021
Q4 		$5K Sell
3,900
-1,100
-22% -$1.75K ﹤0.01% 7668
2021
Q3 		$10K Buy
+5,000
New +$8.86K ﹤0.01% 7520
2020
Q3 		– Sell
-13,400
Closed -$48K – 6694
2020
Q2 		$48K Buy
13,400
+10,700
+396% +$33.8K ﹤0.01% 4396
2020
Q1 		$6K Sell
2,700
-3,300
-55% -$9.26K ﹤0.01% 4751
2019
Q4 		$13K Sell
6,000
-900
-13% -$1.78K ﹤0.01% 4534
2019
Q3 		$13K Buy
6,900
+2,200
+47% +$3.85K ﹤0.01% 4522
2019
Q2 		$7K Buy
4,700
+3,500
+292% +$6.12K ﹤0.01% 4533
2019
Q1 		$2K Sell
1,200
-23,700
-95% -$50.3K ﹤0.01% 4617
2018
Q4 		$33K Buy
24,900
+4,000
+19% +$7.32K ﹤0.01% 3769
2018
Q3 		$51K Buy
20,900
+200
+1% +$591 ﹤0.01% 3961
2018
Q2 		$70K Buy
20,700
+19,100
+1,194% +$73.4K ﹤0.01% 3770
2018
Q1 		$7K Sell
1,600
-3,100
-66% -$10.7K ﹤0.01% 4438
2017
Q4 		$16K Buy
4,700
+2,200
+88% +$8.02K ﹤0.01% 4231
2017
Q3 		$10K Sell
2,500
-45,000
-95% -$171K ﹤0.01% 4308
2017
Q2 		$209K Sell
47,500
-1,400
-3% -$5.75K ﹤0.01% 2615
2017
Q1 		$178K Sell
48,900
-37,400
-43% -$123K ﹤0.01% 2600
2016
Q4 		$230K Sell
86,300
-91,200
-51% -$283K ﹤0.01% 2330
2016
Q3 		$579K Buy
177,500
+161,700
+1,023% +$529K 0.01% 1707
2016
Q2 		$53K Sell
15,800
-40,900
-72% -$100K ﹤0.01% 3279
2016
Q1 		$138K Buy
56,700
+33,200
+141% +$78.5K ﹤0.01% 2595
2015
Q4 		$77K Buy
23,500
+18,700
+390% +$62.7K ﹤0.01% 3160
2015
Q3 		$17K Buy
+4,800
New +$11.2K ﹤0.01% 4116
2015
Q2 		– Sell
-2,200
Closed -$2K – 5269
2015
Q1 		$2K Sell
2,200
-600
-21% -$283 ﹤0.01% 4585
2014
Q4 		$1K Sell
2,800
-13,900
-83% -$29.7K ﹤0.01% 4793
2014
Q3 		$73K Buy
16,700
+1,400
+9% +$6.86K ﹤0.01% 3261
2014
Q2 		$76K Buy
15,300
+8,000
+110% +$41.2K ﹤0.01% 3232
2014
Q1 		$40K Buy
7,300
+7,100
+3,550% +$41.2K ﹤0.01% 3789
2013
Q4 		$1K Sell
200
-7,700
-97% -$52.5K ﹤0.01% 5144
2013
Q3 		$52K Buy
7,900
+4,400
+126% +$28.7K ﹤0.01% 3516
2013
Q2 		$18K Buy
+3,500
New +$17.7K ﹤0.01% 4140

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Group One Trading's NYMX Position: Q3 2023 in Review

Group One Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 5,307 shares — an estimated $1.01K sold.

Group One Trading first reported a position in NYMX in Q2 2013 and held it in 34 quarters. The position peaked at $295K in Q4 2017. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Group One Trading reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 5,307 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $1.01K.
  • Group One Trading first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 34 quarters.
  • Group One Trading's Nymox Pharmaceutical Corp position peaked at $295K in Q4 2017.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.